Ebola patient tests negative in Copenhagen

A Doctors without Borders employee who recently returned from west Africa tested negative for Ebola at Hvidore Hospital.

Ebola patient tests negative in Copenhagen
Photo: Hvidore Hospital
Update, 6.32pm:
A Danish Doctors without Borders employee who checked in to Hvidore Hospital under the suspicion of having contracted Ebola in west Africa tested negative for the virus, an initial blood test performed by the Danish State Serum institute revealed. Hvidore Hospital will perform one additional test on Friday morning before ruling with 100 percent certainty that the patient is negative, the hospital said in a press release. 
“New findings show that a few days can pass from when the symptoms first appear until viruses can be detected in tests. Therefore, we will maintain emergency precautions for 24 hours and have another test taken to be completely on the safe side,” hospital spokesman Torben Mogensen said. 
Original, 1.20pm:
A patient was admitted to Hvidore Hospital on Thursday for suspicion of having the Ebola virus, according to the Danish Health and Medicines Authority (Sundhedsstyrelsen). 
“Hvidore Hospital has admitted a patient to clarify a possible Ebola infection and is dealing with the patient under Sundhedsstyrelsen’s guidelines for the handling of the Ebola virus until the diagnosis can be disproved or confirmed,” the agency said in a statement. 
A blood sample from the patient has been sent to the Danish State Serum Institute and health officials say the results will come back later on Thursday. 
The Danish branch of Doctors without Borders (Læger uden Grænsen) announced in a press release that the patient is one of its employees and that the person has recently been in west Africa.
“The person in question was sent to west Africa by Doctors without Borders in connection with the latest outbreak of Ebola. After leaving the country, the person monitored their temperature and health conditions. After observing a slight temperate increase, Sundhedsstyrelsen and Hvidore Hosptial were informed and emergency plans were set in motion,” a statement read. 
The Doctors without Borders statement stressed that a rise in temperature could be due to many things besides an Ebola infection. 

Hvidore Hospital, which is located in the suburban Copenhagen area, was the site of a previous Ebola scare earlier this month after another patient who had been in west Africa displayed symptoms consistent with Ebola. Hospital staff isolated the individual, but within a few hours doctors were able to rule out an infection.  
There was also a false Ebola alarm on Tuesday at a Copenhagen police station. In that instance, an African man who had recently been in Nigeria was brought into Station City and displayed symptoms “that the police couldn’t rule out” were consistent with Ebola. A doctor was called to the scene and quickly determined that the man did not have the virus. 
The Local will have more on the current Ebola scare as soon as more information becomes available.

Member comments

Log in here to leave a comment.
Become a Member to leave a comment.


Ebola tests sold to Denmark recalled

The US Food and Drug Administration said that Ebola kits sent to Denmark and other countries could result in "life-threatening" false positives.

Ebola tests sold to Denmark recalled
Photo: Colourbox
US regulators have issued an international recall for a 10-minute Ebola blood test made by a California-based company, saying it has not been proven to work and could put lives at risk.
"A recall has been issued for the LuSys Laboratories, Inc., Ebola Virus One-Step Test Kits because the FDA has not cleared or approved the kits for use or sale," said the Food and Drug Administration in a statement emailed to reporters on Thursday.
"The results obtained from these test kits have not demonstrated to be accurate and should not be used as in vitro diagnostic tests for Ebola infection."
The recall was initially issued in mid-March and applies to test kits exported to Denmark, Sierra Leone and Canada between October 2014 and January 2015.
The FDA did not say how many tests were sent out.
The recall is described as a Class I, "the most serious type of recall and involve(s) situations in which there is a reasonable probability that use of these products will cause serious adverse health consequences or death," the FDA said.
"A false positive result may be life-threatening by potentially placing the patient in an isolation cohort with Ebola-infected patients."
Contacted by AFP, a company representative in San Diego said early trials have shown the test to be 86 percent accurate.
The problem with the FDA came down to a labeling error, he said. The equipment had not been properly labeled "for research purposes only."